Cic edizioni internazionali
Research and Advances in Psychiatry

May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview

Review article, 48 - 58
Tag this article
Abstract
Enhanced HTML Full text PDF
Schizophrenia is a chronic and disabling disorder, characterized by positive, negative, cognitive and affective symptoms. The first episode of schizophrenia (FES) usually occurs after a variable period of prodromic symptoms and the importance of early detection and treatment of FES has been raised in psychiatric literature from long time. In fact, it has been suggested that the first years of the schizophrenic disorder may be a critical period for long-term prognosis, as the relationship between the poor medication adherence and poorer outcome is well demonstrated. Longacting injectable formulations of second-generation antipsychotics (SGAs-LAIs) provide constant medication delivery and the potential for improved adherence. Currently, four SGAs-LAIs are available for the treatment of schizophrenia, risperidone long-acting injectable, olanzapine pamoate, paliperidone palmitate and aripiprazole.
Several studies have also demonstrated efficacy and safety of such drugs in patients with schizophrenia.
In the present paper the literature on SGAs-LAIs atypical antipsychotics in the treatment of FES will be reviewed and practical advice will be given concerning the use of this drug in the everyday clinical practice.

Vol. 5 (No. 2) 2018 May - August

  1. Change in personality over time according to the Drug-of-Choice: a longitudinal study in a community-based treatment program for drug abusers
    Nivoli A.A.M., Antonioli M., Ricci G., Floris L., Porcu P., Lorettu L.
  2. The interaction between skin and mind: the case of body dysmorphic disorder
    Al-Sarraf A., Khatib Y., Corazza O.
  3. Substance use and psychiatric consequences: a case series
    Montemitro C., Sarchione F., Corbo M., Santacroce R., Catalano G., Baroni G., Pasquini A., Piro L., D'Arpa A., Di Giannantonio M., Martinotti G., Schifano F., Giorgetti R., Gordillo M.J., del Villar C.M.
  4. Post-traumatic stress and substance misuse; neurobiological and clinical pharmacological correlates
    Schifano F., Duccio Papanti G., Corkery J.M., Orsolini L.
  5. The delusional experience in cocaine-induce psychosis: a case report
    Ferro F.M., Martinotti G., de Falco A., De Risio L.
Last Viewed articles: la lista degli ultimi x visitati.
  1. May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview
    De Berardis D., Serroni N., Olivieri L., Gianfelice D., Iasevoli F., Tomasetti C., de Batolomeis A., Mazza M., Valchera A., Fornaro M., Di Fabio F., Cavedini P., Perna G., Piersanti M., Di Nicola M., Odorisio M., Carano A., Vellante F., Matarazzo I., Di Giannantonio M.
credits